Q-omics provides the consensus-scored RPS3AP54 profile across patient tissues and cancer cell-line models. RPS3AP54 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, RPS3AP54 is differentially expressed in 11, with the highest sampling consensus in THCA. Additionally, RPS3AP54 RNA expression shows 12,156 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight KICH, THCA, and TGCT as cancer lineages where RPS3AP54 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RPS3AP54 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RPS3AP54 survival associations across molecular data types. RPS3AP54 RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RPS3AP54 RNA expression–survival associations across cancer types. High RPS3AP54 expression shows unfavorable associations in KICH, UCEC, THCA, CESC, MESO and STAD. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KICH as the clearest survival context for RPS3AP54 RNA expression.
This table summarizes RPS3AP54 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for RPS3AP54. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RPS3AP54 shows lower tumor expression in THCA and higher tumor expression in LIHC, UCEC, KIRP, BRCA and HNSC. The THCA box plot shows higher RPS3AP54 RNA expression in normal versus tumor tissue (log2 FC = −0.343, t-test p < 0.001).
This table shows molecular features associated with RPS3AP54 in patient tissues and cancer cell lines. In patient samples, RPS3AP54 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
